Nov 08, 2018 12:30pm EST BioReference Laboratories Named as Preferred Laboratory with Horizon Healthcare Services
Nov 08, 2018 9:12am EST OPKO Health to Announce Third Quarter 2018 Financial Results on November 9, 2018
Aug 28, 2018 8:00am EDT OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
Aug 03, 2018 1:29pm EDT OPKO Health Completes Enrollment in Global Phase 3 Study of Somatrogon (hGH-CTP) in Growth Hormone Deficient Children